Evidence map›Paper›PMID 41390694›Full record

ArticleScientific reports2025

Developing 400 MPa grade biodegradable Zn alloys with superior osteogenic and antibacterial performance.

Jiawei Cai, Qiang Li, Shikai Li, Yan Chengyue, Zhe Liu, Zhiyong Zhang, Bin Cheng

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiawei Cai *Translational Research Centre of Regenerative Medicine and 3D Printing, Guangdong Province Engineering Research Center for Biomedical Engineering, State Key Laboratory of Respiratory Disease, Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, Guangdong, P.R. China.
Qiang Li *The Second Orthopedic Department of Zhangzhou Zhengxing Hospital, Zhangzhou, 363000, Fujian, P.R. China.
Shikai LiTranslational Research Centre of Regenerative Medicine and 3D Printing, Guangdong Province Engineering Research Center for Biomedical Engineering, State Key Laboratory of Respiratory Disease, Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, Guangdong, P.R. China.
Yan ChengyueTranslational Research Centre of Regenerative Medicine and 3D Printing, Guangdong Province Engineering Research Center for Biomedical Engineering, State Key Laboratory of Respiratory Disease, Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, Guangdong, P.R. China.
Zhe LiuTranslational Research Centre of Regenerative Medicine and 3D Printing, Guangdong Province Engineering Research Center for Biomedical Engineering, State Key Laboratory of Respiratory Disease, Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, Guangdong, P.R. China.
Zhiyong ZhangTranslational Research Centre of Regenerative Medicine and 3D Printing, Guangdong Province Engineering Research Center for Biomedical Engineering, State Key Laboratory of Respiratory Disease, Department of Orthopaedic Surgery, Guangzhou Key Laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, Guangdong, P.R. China. drzhiyong_pa@126.com.ORCID http://orcid.org/0000-0002-7222-2652
Bin ChengThe Second Orthopedic Department of Zhangzhou Zhengxing Hospital, Zhangzhou, 363000, Fujian, P.R. China. zxcb0304@163.com.ORCID http://orcid.org/0009-0003-0842-8650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biodegradable zinc (Zn) has emerged as a promising orthopedic implant material, capable of supporting bone repair while gradually resorbing in the body. Yet, its relatively low strength has restricted its use in high load-bearing scenarios. The addition of lithium (Li) improves mechanical strengths of Zn alloys, of which are comparable to that of pure Ti. Here, we present a Zn-0.8Li alloy system enhanced through alloying and equal channel angular pressing (ECAP). By tuning the processing temperature, the alloys attained superior mechanical performance, with tensile strength reaching 434 MPa and elongation of 65% at 200 °C. The dominant strengthening mechanisms were identified as grain boundary strengthening and dislocation strengthening. Corrosion assessment revealed a stable degradation rate of ~ 5.5 μm/year after 30 days of immersion, with localized attack at second phases and grain boundary corrosion in ultrafine-grained microstructures (T-150 and T-200 samples), whereas a fine-grained microstructure (T-300 sample) exhibited suppressed boundary corrosion. In vitro studies confirmed excellent cytocompatibility and osteogenic potential of the ECAP-treated Zn-0.8Li alloys compared with bioinert Ti. Furthermore, antibacterial tests demonstrated inhibition rates exceeding 90% against E. coli colonies.

Indexed as

AlloysAnti-Bacterial AgentsBiocompatible MaterialsOsteogenesisZincAbsorbable ImplantsAnimalsCorrosionEscherichia coliLithiumMaterials TestingMiceTensile StrengthAlloysAnti-Bacterial AgentsBiocompatible MaterialsLithiumZincEqual channel angular pressingMechanical propertiesOsteogenesisZinc alloys

Identifiers

PMID41390694
PMCPMC12820216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.